Business & Industry
Oral-B highlighs iO toothbrush at CES
January 12, 2021 -- Proctor & Gamble (P&G) said that its Oral-B brand is showcasing its iO toothbrush at this week's CES 2021 consumer electronics show.
Aspen Dental teams up with 3Shape
January 12, 2021 -- Aspen Dental Management has inked a deal with 3Shape to equip its Aspen Dental locations in the U.S.
Nobel Biocare launches Xeal, TiUltra surfaces in U.S.
January 12, 2021 -- Nobel Biocare has launched its Xeal and TiUltra surfaces in the U.S. for dental implants and abutments.
Philips unveils Sonicare 9900 Prestige with SenseIQ technology
January 11, 2021 -- Philips has introduced Philips Sonicare 9900 Prestige, the company's latest and most advanced edition of its flagship electric toothbrush.
Univ. at Buffalo launches program to increase diversity
January 11, 2021 -- The University at Buffalo School of Dental Medicine has launched Destination Dental School, a program aimed to increase dental school enrollment for students from underrepresented backgrounds.
CDA provides COVID-19 vaccine information
January 11, 2021 -- The California Dental Association (CDA) has provided updated information for dentists on COVID-19 vaccination in the state.
P&G commits to lofty oral care goal by 2030
January 11, 2021 -- Procter & Gamble (P&G) Oral Care has created a new sustainability platform to support reducing environmental impact while achieving optimal oral health.
In Curve Hero, how do I discover outstanding accounts receivable per provider?
January 8, 2021 -- It's important to know where your business stands as you prepare for what is to come in 2021. Having reports at your fingertips is key, as is knowing where to find them. Tracey Thompson offers some tips and advice on how to access reports in the Curve Hero practice management software to help settle accounts receivable questions.  Discuss
Dental Board of California offers expedited licensure for certain individuals
January 8, 2021 -- The Dental Board of California is expediting the licensure process for refugees, asylum seekers, and individuals with special immigrant visas.
OncoZenge announces European patent for BupiZenge lozenge
January 8, 2021 -- Moberg Pharma subsidiary OncoZenge announced that the European Patent Office has granted the firm patent No. 3,284,459, which protects its BupiZenge lozenge.